These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


246 related items for PubMed ID: 8207225

  • 21. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B, Mitsdoerffer M, Kieseier BC, Chen L, Hartung HP, Weller M, Wiendl H.
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [Abstract] [Full Text] [Related]

  • 22. Interferon-gamma secretion by peripheral blood T-cell subsets in multiple sclerosis: correlation with disease phase and interferon-beta therapy.
    Becher B, Giacomini PS, Pelletier D, McCrea E, Prat A, Antel JP.
    Ann Neurol; 1999 Feb; 45(2):247-50. PubMed ID: 9989628
    [Abstract] [Full Text] [Related]

  • 23. IFN-beta inhibits the ability of T lymphocytes to induce TNF-alpha and IL-1beta production in monocytes upon direct cell-cell contact.
    Jungo F, Dayer JM, Modoux C, Hyka N, Burger D.
    Cytokine; 2001 Jun 07; 14(5):272-82. PubMed ID: 11444907
    [Abstract] [Full Text] [Related]

  • 24. The cytokine microenvironment of human colon carcinoma. Lymphocyte expression of tumor necrosis factor-alpha and interleukin-4 predicts improved survival.
    Barth RJ, Camp BJ, Martuscello TA, Dain BJ, Memoli VA.
    Cancer; 1996 Sep 15; 78(6):1168-78. PubMed ID: 8826937
    [Abstract] [Full Text] [Related]

  • 25. Natural cytotoxic activity in multiple sclerosis patients: defects in IL-2/interferon gamma-regulatory circuit.
    Braakman E, van Tunen A, Meager A, Lucas CJ.
    Clin Exp Immunol; 1986 Nov 15; 66(2):285-94. PubMed ID: 2949897
    [Abstract] [Full Text] [Related]

  • 26. TGF-beta as a promising option in the treatment of multiple sclerosis.
    Mirshafiey A, Mohsenzadegan M.
    Neuropharmacology; 2009 Nov 15; 56(6-7):929-36. PubMed ID: 19285095
    [Abstract] [Full Text] [Related]

  • 27. Intraepithelial lymphocytes in human gut have lytic potential and a cytokine profile that suggest T helper 1 and cytotoxic functions.
    Lundqvist C, Melgar S, Yeung MM, Hammarström S, Hammarström ML.
    J Immunol; 1996 Sep 01; 157(5):1926-34. PubMed ID: 8757311
    [Abstract] [Full Text] [Related]

  • 28. Production of hematopoietic regulatory cytokines by peripheral blood mononuclear cells in patients with aplastic anemia.
    Hsu HC, Tsai WH, Chen LY, Hsu ML, Ing-Tiau Kuo B, Ho CH, Lin CK, Wang SY.
    Exp Hematol; 1996 Jan 01; 24(1):31-6. PubMed ID: 8536789
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Airway infection in stable lung transplant patients is associated with decreased intracellular T-helper type 1 pro-inflammatory cytokines in bronchoalveolar lavage T-cell subsets.
    Hodge G, Hodge S, Reynolds PN, Holmes M.
    Transpl Infect Dis; 2008 Apr 01; 10(2):99-105. PubMed ID: 17511818
    [Abstract] [Full Text] [Related]

  • 32. Persistent production of inflammatory and anti-inflammatory cytokines and associated MHC and adhesion molecule expression at the site of infection and disease in experimental Trypanosoma cruzi infections.
    Zhang L, Tarleton RL.
    Exp Parasitol; 1996 Nov 01; 84(2):203-13. PubMed ID: 8932770
    [Abstract] [Full Text] [Related]

  • 33. Infliximab downregulates interferon-gamma production in activated gut T-lymphocytes from patients with Crohn's disease.
    Agnholt J, Kaltoft K.
    Cytokine; 2001 Aug 21; 15(4):212-22. PubMed ID: 11563881
    [Abstract] [Full Text] [Related]

  • 34. Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis.
    Correale J, Gilmore W, McMillan M, Li S, McCarthy K, Le T, Weiner LP.
    J Immunol; 1995 Mar 15; 154(6):2959-68. PubMed ID: 7533188
    [Abstract] [Full Text] [Related]

  • 35. Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis: a correlation with clinical activity.
    Carrieri PB, Provitera V, De Rosa T, Tartaglia G, Gorga F, Perrella O.
    Immunopharmacol Immunotoxicol; 1998 Aug 15; 20(3):373-82. PubMed ID: 9736442
    [Abstract] [Full Text] [Related]

  • 36. Organ-specific autoantigens induce transforming growth factor-beta mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis.
    Link J, Fredrikson S, Söderström M, Olsson T, Höjeberg B, Ljungdahl A, Link H.
    Ann Neurol; 1994 Feb 15; 35(2):197-203. PubMed ID: 7509140
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.